constipation. Constipation
Conditions
Interventions
Intervention 1: dose of consumption:a glass of boiled water(0.25 liter)+a spoon of laxative herbal powder (1 gram)every other day before breakfast.
research will done in 4 weeks(1 month)and in 14 tim
Treatment - Drugs
dose of consumption:a glass of boiled water(0.25 liter)+a spoon of laxative herbal powder (1 gram)every other day before breakfast.
research will done in 4 weeks(1 month)and in 14 times( times in ea
dose of consumption:a glass of boiled water(0.25 liter)+a spoon of Prepared placebo powder(1 gram)every other day before breakfast. research will done in 4 weeks(1 month)and in 14 times( times in each
Sponsors
vice chancellor for Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria:suffering from constipation based on romIII criteria and non-use constiepation drugs in last month.(in selection of patients we try that cases similar in age and severity of disease) exclusion criteria:secondary constipation beceause of drugs or other disease,quit the research,treatment with other antie constipation drugs,side effect of experiemental treatment.cases with hepatic,renal,cardiac,pulmonary,haematologicand brain disorder.cases with cancer,inflammatory bowel disease,hiestory of allergy to the herbals,alcholism,acetive addiction,pregnancy,breast feeding and history of gastrointestinal blleding.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of constipation(based on number of defecation per week and defection difficulties). Timepoint: befor intervention,every other day after intervention and 2 weeks after the end of intervention. Method of measurement: romIII criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Probable side effect and toleration to the drug during the study. Timepoint: probable side effect and toleration to the drug during the study. Method of measurement: probable side effect and toleration to the drug during the study. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasood Bagheri
Inteligence room of Tabriz University of Medical Sciences/research room of Tabriz University of Medi
Outcome results
None listed